ConductScience.org, home

Paper · 36459568

Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.

Williams HL and 38 others. Cancer Res, 2023. Cited by 95 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity. Papers, record 36459568. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36459568

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.
PubMed
Journal
Cancer Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
7.19
iCite
Revised in PubMed
2026-07-26
PubMed

Authors39

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Humans
Prognosis
Phenotype
RNA
Gene Expression Regulation, Neoplastic
Claudins

Source PubMed

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R35 CA197735NCI NIH HHSUnited StatesR35CA197735PubMedNIH RePORTER
U01 CA210171NCI NIH HHSUnited StatesU01CA210171PubMed and NIHNIH RePORTER
R01 CA248857NCI NIH HHSUnited StatesR01CA248857PubMedNIH RePORTER
P30 ES001247NIEHS NIH HHSUnited StatesP30ES001247PubMedNIH RePORTER
R01 CA276268NCI NIH HHSUnited StatesR01CA276268PubMed and NIHNIH RePORTER
R01 CA205406NCI NIH HHSUnited StatesR01CA205406PubMedNIH RePORTER
R01 CA169141NCI NIH HHSUnited StatesR01CA169141PubMedNIH RePORTER
U01 CA250549NCI NIH HHSUnited StatesU01CA250549PubMed and NIHNIH RePORTER
P50 CA127003NCI NIH HHSUnited StatesP50CA127003PubMedNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134,644,529Spatially confined sub-tumor microenvironments in pancreatic cancer.Cell2021https://conductscience.org/library/papers/34644529PubMed
232,629,389Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer.EBioMedicine2020https://conductscience.org/library/papers/32629389PubMed
331,375,762Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer.Sci Rep2019https://conductscience.org/library/papers/31375762PubMed
431,395,068Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.Radiat Oncol2019https://conductscience.org/library/papers/31395068PubMed
529,903,880Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.Cancer Discov2018https://conductscience.org/library/papers/29903880PubMed
626,343,385Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.Nat Genet2015https://conductscience.org/library/papers/26343385PubMed
733,324,659Keratin 17 Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Pancreatic Cancer.Front Med (Lausanne)2020https://conductscience.org/library/papers/33324659PubMed
833,262,135Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer.Clin Cancer Res2021https://conductscience.org/library/papers/33262135PubMed
925,488,926Updated UK Recommendations for HER2 assessment in breast cancer.J Clin Pathol2015https://conductscience.org/library/papers/25488926PubMed
1031,201,285Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.Gut2020https://conductscience.org/library/papers/31201285PubMed

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
42,876,041Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy.Cancer Med2026https://conductscience.org/library/papers/42876041PubMed
42,738,256The Classical-Basal Spectrum in Pancreatic Ductal Adenocarcinoma: A Developmental Framework for Tumour Cell Plasticity and Clinical Translation.Cancers (Basel)2026https://conductscience.org/library/papers/42738256PubMed
42,649,389Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer.Nat Genet2026https://conductscience.org/library/papers/42649389PubMed
42,649,211Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer.Nat Commun2026https://conductscience.org/library/papers/42649211PubMed
42,632,864Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics.Br J Cancer2026https://conductscience.org/library/papers/42632864PubMed
42,523,238The basal cell state maintains pancreatic cancers by controlling an immunosuppressive circuit.bioRxiv2026https://conductscience.org/library/papers/42523238PubMed
42,476,970LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming.Cell Death Dis2026https://conductscience.org/library/papers/42476970PubMed
42,439,673Spatial-Niche Perspective on the Heterogeneity and Functional Reprogramming of Tumor-Associated Macrophages in Digestive System Tumors.Cells2026https://conductscience.org/library/papers/42439673PubMed
42,346,787Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition.Mar Drugs2026https://conductscience.org/library/papers/42346787PubMed
42,225,812Rapid autofluorescence based 3D optical imaging of the pancreatic cancer milieu at mesoscopic scale - stain-free volumetric segmentation.Sci Rep2026https://conductscience.org/library/papers/42225812PubMed

1 to 10 of 70

See all 70 cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

1 to 10 of 11

See all 11 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36459568

GET https://conductscience.org/api/papers/v1/36459568/authors?page=2